Literature DB >> 9094977

Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.

S A Pileri1, K Pulford, S Mori, D Y Mason, E Sabattini, G Roncador, M Piccioli, C Ceccarelli, P P Piccaluga, D Santini, O Leone, H Stein, B Falini.   

Abstract

The revised European-American lymphoma classification recognizes a subtype of anaplastic large-cell lymphoma (ALCL), termed lympho-histiocytic because of its peculiar cytological composition. As in the case of classical ALCL, this tumor usually occurs in young patients and shows an excellent response to chemotherapy, but some authors have suggested that in reality this is a nonanaplastic T-cell lymphoma rich in histiocytes. In this paper, we show that three of five cases of lympho-histiocytic ALCL stain with anti-ALK antibodies and can therefore be presumed to express the chimeric NPM/ALK protein secondary to (2;5) translocation. These findings further support the inclusion of this as a type of ALCL and not among the nonanaplastic peripheral T-cell lymphomas. Furthermore, they indicate that staining for ALK proteins is a powerful tool for the diagnosis of lympho-histiocytic ALCL, the recognition of which may be difficult on morphological grounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094977      PMCID: PMC1858171     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

Review 1.  The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma.

Authors:  H Stein; H Herbst; I Anagnostopoulos; G Niedobitek; F Dallenbach; H C Kratzsch
Journal:  Ann Oncol       Date:  1991-02       Impact factor: 32.976

2.  Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.

Authors:  S Pileri; M Bocchia; C D Baroni; M Martelli; B Falini; E Sabattini; F Gherlinzoni; S Amadori; S Poggi; P Mazza
Journal:  Br J Haematol       Date:  1994-03       Impact factor: 6.998

3.  A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma').

Authors:  R Rimokh; J P Magaud; F Berger; J Samarut; B Coiffier; D Germain; D Y Mason
Journal:  Br J Haematol       Date:  1989-01       Impact factor: 6.998

4.  A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis.

Authors:  Y Kaneko; G Frizzera; S Edamura; N Maseki; M Sakurai; Y Komada; M Sakurai; H Tanaka; M Sasaki; T Suchi
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

5.  CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35.

Authors:  D Y Mason; C Bastard; R Rimokh; N Dastugue; J L Huret; U Kristoffersson; J P Magaud; C Nezelof; H Tilly; J P Vannier
Journal:  Br J Haematol       Date:  1990-02       Impact factor: 6.998

6.  Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases.

Authors:  A Chott; K Kaserer; I Augustin; M Vesely; R Heinz; W Oehlinger; H Hanak; T Radaszkiewicz
Journal:  Am J Surg Pathol       Date:  1990-05       Impact factor: 6.394

7.  Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes).

Authors:  S Pileri; B Falini; G Delsol; H Stein; P Baglioni; S Poggi; M F Martelli; M T Rivano; D Y Mason; A G Stansfeld
Journal:  Histopathology       Date:  1990-04       Impact factor: 5.087

8.  Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.

Authors:  F Bullrich; S W Morris; M Hummel; S Pileri; H Stein; C M Croce
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

9.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  12 in total

1.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

Authors:  B Lawrence; A Perez-Atayde; M K Hibbard; B P Rubin; P Dal Cin; J L Pinkus; G S Pinkus; S Xiao; E S Yi; C D Fletcher; J A Fletcher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Hematolymphoid lesions of the sinonasal tract.

Authors:  Genevieve M Crane; Amy S Duffield
Journal:  Semin Diagn Pathol       Date:  2015-09-09       Impact factor: 3.464

3.  ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

Authors:  B Falini; B Bigerna; M Fizzotti; K Pulford; S A Pileri; G Delsol; A Carbone; M Paulli; U Magrini; F Menestrina; R Giardini; S Pilotti; A Mezzelani; B Ugolini; M Billi; A Pucciarini; R Pacini; P G Pelicci; L Flenghi
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 4.  Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.

Authors:  Naoko Tsuyama; Kana Sakamoto; Seiji Sakata; Akito Dobashi; Kengo Takeuchi
Journal:  J Clin Exp Hematop       Date:  2017

Review 5.  Pharmacotherapeutic Management of Pediatric Lymphoma.

Authors:  Christine Mauz-Körholz; Natascha Ströter; Julia Baumann; Ante Botzen; Katharina Körholz; Dieter Körholz
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

Review 6.  Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes.

Authors:  Justine M Kahn; Nmazuo W Ozuah; Kieron Dunleavy; Tara O Henderson; Kara Kelly; Ann LaCasce
Journal:  Blood Adv       Date:  2017-10-10

Review 7.  Hodgkin's lymphoma: the pathologist's viewpoint.

Authors:  S A Pileri; S Ascani; L Leoncini; E Sabattini; P L Zinzani; P P Piccaluga; A Pileri; M Giunti; B Falini; G B Bolis; H Stein
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

8.  Morphological variability of lymphohistiocytic variant of anaplastic large cell lymphoma (former lymphohistiocytic lymphoma according to the Kiel classification).

Authors:  Wolfram Klapper; Matthias Böhm; Reiner Siebert; Karl Lennert
Journal:  Virchows Arch       Date:  2008-05-14       Impact factor: 4.064

9.  Pathobiology of anaplastic large cell lymphoma.

Authors:  Pier Paolo Piccaluga; Anna Gazzola; Claudia Mannu; Claudio Agostinelli; Francesco Bacci; Elena Sabattini; Carlo Sagramoso; Roberto Piva; Fernando Roncolato; Giorgio Inghirami; Stefano A Pileri
Journal:  Adv Hematol       Date:  2011-02-06

10.  Pathobiology of ALK-negative anaplastic large cell lymphoma.

Authors:  Stefano A Pileri; Claudio Agostinelli; Francesco Bacci; Elena Sabattini; Carlo Sagramoso; Brunangelo Falini; Pier Paolo Piccaluga
Journal:  Pediatr Rep       Date:  2011-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.